Xin Hu – Trademark Portfolio
Entity Type: 01
Xin Hu has 6 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 50% registration rate, with 2 applications currently pending. The portfolio includes marks such as ZORVANTA and FLORIANETIX. Filings span 5 Nice Classification classes, with the highest activity in Class 9 (Computers & Electronics) and Class 10 (Medical Apparatus). This trademark owner is based in Changning , Hunan.
No.5, Liujia villager Group,Xinjian Village, Baifang Town,
Changning , Hunan 421521 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xin Hu's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Frequently Asked Questions
How many trademarks does Xin Hu have?
Xin Hu has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending, 2 abandoned.
What trademark classes does Xin Hu file in?
Xin Hu files trademarks across 5 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 27 (Floor Coverings), Class 43 (Hotels & Restaurants). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Xin Hu's most well-known trademarks?
Xin Hu's registered trademark portfolio includes well-known marks such as ZORVANTA and FLORIANETIX. These are among 2 currently registered trademarks in the portfolio.
What is Xin Hu's trademark registration success rate?
Xin Hu has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 2 applications are pending review.